SNMMI Annual Meeting 2025

DOSIsoft participates in the Annual Meeting of SNMMI (Society of Nuclear Medecine and Molecular Imaging)

PLANET^®  Onco Dose v3.2

Multi-radionuclide, multi-workflow, multi-therapy enabling voxel-based personalized dosimetry for SIRT & MRT

DOSIsoft Booth #1053

With FDA 510(k) clearance for U.S. marketing, the latest release—PLANET^® Onco Dose v3.2—is a next-generation dosimetry platform built to support multi-radionuclide capabilities, diverse workflows, and a wide range of therapy applications.

The software features advanced voxel-based dose computation for ⁹⁰Y-SIRT as well as ¹⁷⁷Lu and ¹³¹I-based MRT therapies, with the flexibility to incorporate emerging beta and gamma emitters. Clinicians can choose between multi-time point or the newly introduced single-time point dosimetry workflows—streamlining clinical processes, reducing workload, and improving patient comfort while maintaining high dosimetric accuracy.